GeneLink, Inc. Subsidiary GeneWize Launches Revolutionary LifeMap Me(TM) DNA Customized Skin Serum

ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink, Inc. (OTCBB: GNLK.OB) (the “Company”), a leading consumer genomics biotech company, today reported that its wholly owned subsidiary, GeneWize Life Sciences, Inc. (“GeneWize”), launched its new LifeMap Me™ DNA customized skin serum and welcomed leaders and sales professionals (Affiliates) from across the nation to Orlando, Florida to celebrate first year sales of over $11M and enjoy three days of recognition, learning and festivity.